Averting a malaria disaster in Africa - Where does the buck stop?

Bulletin of the World Health Organization

Volumn 82, Issue 5, 2004, Pages 381-384

  Whitty, Christopher J M ^a   Allan, Richard ^b   Wiseman, Virginia ^a   Ochola, Sam ^c   Nakyanzi Mugisha, Maria Veronicah ^d   Vonhm, Benjamin ^e   Mwita, Mahemba ^f   Miaka, Constantin ^g   Oloo, Aggrey ^h   Premji, Zul ⁱ   Burgess, Craig ^j   Mutabingwa, Theonest K ^a,k  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c MINISTRY OF HEALTH   (Kenya)

^d Ministry of Health   (Rwanda)

^e National Malaria Control Programme   (Liberia)

^f Elderly and Children   (Tanzania)

^g Ministry of Health   (Congo)

^h MOI UNIVERSITY   (Kenya)

ⁱ MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^j Med Emergency Relief International   (United Kingdom)

^k East African Antimalarial Network   (Tanzania)

more..

Author keywords

Africa; Antimalarials economics; Artemisinins economics; Drug costs; Drug therapy, Combination; Financing, Organized; Malaria, Falciparum drug therapy; Patient acceptance of health care

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISIN; CHLOROQUINE; CHLORPROGUANIL PLUS DAPSONE; FANSIDAR;

COST; DISEASE CONTROL; DRUG RESISTANCE; FINANCIAL PROVISION; MALARIA;

AFRICA; COMBINATION CHEMOTHERAPY; CRISIS INTERVENTION; DISASTER; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HUMAN; MALARIA; POVERTY; REVIEW; SIDE EFFECT;

AFRICA; ANIMALS; ANTIMALARIALS; ARTEMISININS; DISEASE OUTBREAKS; DRUG COSTS; DRUG RESISTANCE, MULTIPLE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

AFRICA;

EID: 2642544141     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, et al. Averting a malaria disaster. Lancet 1999;353:1965-7.
2. Mutabingwa T, Nzila A, Mberu E, Nduati E, Winstanley P, Hills E, et al. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 2001;358:1218-23.
3. Mutabingwa TK, Maxwell CA, Sia IG, Msuya FH, Mkongewa S, Vannithone S, et al. A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 2001;95:433-8.
4. Staedke SG, Kamya MR, Dorsey G, Gasasira A, Ndeezi G, Charlebois ED, et al. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet 2001;358:368-74.
5. Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, et al. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 2002;359:1365-72
6. WHO. Antimalarial drug combination therapy - Report of a WHO Technical Consultation. Geneva: World Health Organization; 2001.
7. Price RN, Nosten F, Luxernburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996;347:1654-8.
8. Bloland PB, Ettling M, Meek S. Combination therapy for malaria in Africa: hype or hope? Bulletin of the World Health Organization, 2000;78:1378-88
9. Ifakara Health Research and Development Centre. IMPACT Tanzania. Interdisciplinary Monitoring Programme for Antimalarial Combination Therapy in Tanzania. 2002. Available from: URL:http://www.mimcom.org. uk/ifakara/impact.htm
10. Kindermans, J-M, Pecoul B, Perez-Casa C, Den Boer M, Berman D, Cox I. Changing national malaria treatment protocols in Africa: What is the cost and who will pay? RBM Partnership Meeting on Improving Access to Antimalarial Treatment. 30 September-2 October 2002. Geneva: World Health Organization; 2002.
11. Marsh K. Malaria disaster in Africa. Lancet 1998;352:924-5.
12. Olliaro P, Taylor WR, Rigal J. Controlling malaria: challenges and solutions. Tropical Medicine and International Health 2001;6:922-7.
13. Stanton B, Clemens J. User fees for health care in developing countries: a case study of Bangladesh. Social Science and Medicine 1989;29:1199-205.
14. Audibert M, Mathonnat J. Cost recovery in Mauritania: initial lessons. Health Policy and Planning 2000;15:66-75.
15. Allan R. Parasites and guns: waging a war on malaria. Africa Health (Medicine Digest) 2001;24:12-3.
16. Allan R, Doull L, van der Wijk J. Cost recovery and malaria treatment in emergencies. The Health Exchange. December 2001. p. 15-9.
17. Marsh VM, Mutemi WM, Muturi J, Haaland A, Watkins WM, Otieno G, et al. Changing home treatment of childhood fevers by training shop keepers in rural Kenya. Tropical Medicine and International Health 1999;4:383-9.
18. Reilley B, Abeyasinghe R, Pakianathar MV. Barriers to prompt and effective treatment of malaria in northern Sri Lanka. Tropical Medicine and International Health 2002;7:744-9.
19. Taylor RB, Shakoor O, Behrens RH, Everard M, Low AS, Wangboonskul J, et al. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet 2001;357:1933-6.
20. Newton P, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, et al. Fake artesunate in southeast Asia. Lancet. 2001;357:1948-50.
21. Gilson L, Russell S, Buse K. The political economy of user fees with targeting: developing equitable health financing policy. Journal of International Development 1995;7:369-401.
22. Wiseman V. Interventions to improve the effectiveness and cost-effectiveness of malaria treatment. London: Report to the Institute of Medicine, Royal Academies; 2003. Available from: URL: http://www.iom.edu/subpage.asp?id=12493
23. Creese A, Bennett, S. Rural risk-sharing strategies. In: Schieber G, Maeda A, editors. Innovations in health care financing: Proceedings of a World Bank Conference 1997. Washington (DC): World Bank. World Bank Discussion Paper No. 365.
24. Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002;415:680-5.
25. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001;358:410-4.
26. Teklehaimanot A, Snow RW. Will the Global Fund help roll back malaria in Africa? Lancet 2002;360:888-9.